Across TCGA pan-cancer cohorts, RNY1P13 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated RNY1P13 data layer.
The strongest signal is observed in thyroid carcinoma (THCA), where higher RNY1P13 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNY1P13 expression acts as an unfavorable survival marker, although some lineages such as LAML and HNSC show a favorable association.
THCA, OV, and LGG are the cancer types where RNY1P13 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.